DK1353904T3 - 1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander - Google Patents

1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander

Info

Publication number: DK1353904T3
Authority: DK; Denmark
Prior art keywords: hydroxytryptamine; ligands; aryl; alkylsulfonylbenzazole; derivatives
Prior art date: 2001-01-23

Application number

DK02720837T

Other languages

English (en)

Inventor

Ping Zhou

Michael Gerard Kelly

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-23

Filing date

2002-01-18

Publication date

2006-02-20

2002-01-18 Application filed by Wyeth Corp filed Critical Wyeth Corp

2006-02-20 Application granted granted Critical

2006-02-20 Publication of DK1353904T3 publication Critical patent/DK1353904T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Cardiology (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

DK02720837T 2001-01-23 2002-01-18 1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander DK1353904T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US26342501P	2001-01-23	2001-01-23

Publications (1)

Publication Number	Publication Date
DK1353904T3 true DK1353904T3 (da)	2006-02-20

Family

ID=23001722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02720837T DK1353904T3 (da)	2001-01-23	2002-01-18	1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander

Country Status (23)

Country	Link
US (4)	US6509357B1 (da)
EP (1)	EP1353904B9 (da)
JP (1)	JP4208573B2 (da)
KR (1)	KR20030068591A (da)
CN (1)	CN1273450C (da)
AR (1)	AR034203A1 (da)
AT (1)	ATE312078T1 (da)
AU (1)	AU2002251811B2 (da)
BR (1)	BR0206633A (da)
CA (1)	CA2435566A1 (da)
DE (1)	DE60207815T2 (da)
DK (1)	DK1353904T3 (da)
EA (1)	EA006057B1 (da)
ES (1)	ES2250638T3 (da)
HU (1)	HUP0401009A3 (da)
IL (1)	IL157059A0 (da)
MX (1)	MXPA03006479A (da)
NO (1)	NO20033300L (da)
NZ (1)	NZ527051A (da)
PL (1)	PL364568A1 (da)
TW (1)	TW593278B (da)
WO (1)	WO2002059088A1 (da)
ZA (1)	ZA200306542B (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20030088508A (ko) *	2001-04-20	2003-11-19	와이어쓰	5-하이드록시트립타민-6 리간드로서의헤테로사이클릴옥시-, -티옥시- 및 -아미노벤즈아졸 유도체
EA200301143A1 (ru) *	2001-04-20	2004-02-26	Уайт	Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
SK16052003A3 (en) *	2001-06-07	2004-10-05	Hoffmann La Roche	New indole derivatives with 5-HT6 receptor affinity
AU2003209114A1 (en) *	2002-02-14	2003-09-04	Wyeth	Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
PL374401A1 (en) *	2002-06-05	2005-10-17	F.Hoffmann-La Roche Ag	1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
WO2004026837A2 (en) *	2002-09-18	2004-04-01	Eli Lilly And Company	Histamine h3 receptor antagonists, preparaton and therapeutic uses
DE60316180T2 (de) *	2002-12-03	2008-05-29	F. Hoffmann-La Roche Ag	Aminoalkoxyindol-derivate als 5-ht6-rezeptorliganden zur bekämpfung von zns-krankheiten
WO2004074243A2 (en) *	2003-02-14	2004-09-02	Wyeth	Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
US7135575B2 (en)	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
SE0302760D0 (sv) *	2003-10-20	2003-10-20	Biovitrum Ab	New compounds
BRPI0508107A (pt)	2004-02-27	2007-07-17	Hoffmann La Roche	derivados de indazol e composições farmacêuticas contendo os mesmos
WO2005085248A1 (en)	2004-02-27	2005-09-15	F.Hoffmann-La Roche Ag	Heteroaryl-fused pyrazolo derivatives
JP2007523938A (ja)	2004-02-27	2007-08-23	エフ．ホフマン−ラ　ロシュ　アーゲー	ピラゾールの縮合誘導体
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
CA2522936C (en) *	2004-10-08	2013-07-23	I-Con Systems, Inc.	Diaphragm valve with electronic pressure detection
ES2318556T3 (es)	2004-11-02	2009-05-01	Pfizer, Inc.	Derivados de sulfonil bencimidazol.
US7538113B2 (en)	2005-02-18	2009-05-26	Wyeth	4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7534796B2 (en)	2005-02-18	2009-05-19	Wyeth	Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en)	2005-02-18	2009-09-01	Wyeth	7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7531542B2 (en)	2005-05-18	2009-05-12	Wyeth	Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en)	2005-05-26	2009-09-01	Wyeth	Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
NZ565872A (en) *	2005-08-15	2011-06-30	Wyeth Corp	Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
AU2006283941A1 (en)	2005-08-25	2007-03-01	F. Hoffmann-La Roche Ag	P38 MAP kinase inhibitors and methods for using the same
PE20070427A1 (es) *	2005-08-30	2007-04-21	Novartis Ag	Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
JP5131990B2 (ja)	2006-01-31	2013-01-30	アレイバイオファーマ、インコーポレイテッド	キナーゼ阻害剤およびその使用方法
WO2007117413A1 (en) *	2006-04-05	2007-10-18	Wyeth	Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
WO2007120596A1 (en) *	2006-04-12	2007-10-25	Wyeth	DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
JP2009538910A (ja) *	2006-06-01	2009-11-12	ワイス	５−ヒドロキシトリプタミン−６リガンドとしての１−スルホニルインダゾリルアミン誘導体および１−スルホニルインダゾリルアミド誘導体
US20090023925A1 (en) *	2007-06-28	2009-01-22	Wyeth	N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles
PE20140192A1 (es)	2010-10-06	2014-02-24	Glaxosmithkline Llc	Derivados de bencimidazol como inhibidores de cinasa pi3
US9663498B2 (en)	2013-12-20	2017-05-30	Sunshine Lake Pharma Co., Ltd.	Aromatic heterocyclic compounds and their application in pharmaceuticals
CN105541693B (zh)	2014-07-08	2018-10-16	广东东阳光药业有限公司	芳杂环类衍生物及其在药物上的应用
WO2018064557A1 (en)	2016-09-30	2018-04-05	Epizyme, Inc.	Substituted fused bi- or tri- heterocyclic compounds as ehmt2 inhibitors
EP3612181A4 (en)	2017-04-21	2021-01-06	Epizyme, Inc.	Combination therapies with ehmt2 inhibitors
WO2019090272A1 (en)	2017-11-06	2019-05-09	Flx Bio, Inc.	Chemokine receptor modulators for treatment of epstein barr virus positive cancer
CN112847099A (zh) *	2021-03-08	2021-05-28	王佳丽	一种有效调节进给量实现自动切割的砂轮切割机

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2905877A1 (de) *	1979-02-16	1980-08-28	Boehringer Mannheim Gmbh	Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0736023B1 (en)	1993-12-21	1998-07-08	Smithkline Beecham Plc	Indole, indoline and quinoline derivatives with 5ht 1d (anti-depressive) activity
GB9416972D0 (en)	1994-08-23	1994-10-12	Smithkline Beecham Plc	Carbon side chain/indole/indolene
GB9600344D0 (en)	1996-01-09	1996-03-13	Lilly Co Eli	Benzimidzolyl neuropeptide y receptor antagonists
EP0871442A1 (en) *	1996-01-09	1998-10-21	Eli Lilly And Company	Benzimidzolyl neuropeptide y receptor antagonists
AU2139097A (en) *	1996-03-01	1997-09-16	Eli Lilly And Company	Methods of treating or preventing sleep apnea
JP3560986B2 (ja)	1997-01-13	2004-09-02	山之内製薬株式会社	５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体
US5872144A (en)	1997-02-18	1999-02-16	American Home Products Corporation	4-aminoethoxyindazole derivatives
US6127380A (en)	1997-02-18	2000-10-03	American Home Products Corporation	4-aminoalkoxy-1H-benzoimidazoles
JP4487019B2 (ja)	1998-03-31	2010-06-23	ランサスメディカルイメージングインコーポレイテッド	血管新生疾患を画像化するための薬剤
GB9820113D0 (en) *	1998-09-15	1998-11-11	Merck Sharp & Dohme	Therapeutic agents
EP1140203B1 (en) *	1998-12-18	2007-05-23	Bristol-Myers Squibb Pharma Company	Vitronectin receptor antagonist pharmaceuticals
GB9902452D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
GB0019950D0 (en) *	2000-08-12	2000-09-27	Smithkline Beecham Plc	Compounds

2001
- 2001-12-26 TW TW090132299A patent/TW593278B/zh not_active IP Right Cessation
2002
- 2002-01-18 BR BR0206633-5A patent/BR0206633A/pt not_active IP Right Cessation
- 2002-01-18 DK DK02720837T patent/DK1353904T3/da active
- 2002-01-18 AT AT02720837T patent/ATE312078T1/de not_active IP Right Cessation
- 2002-01-18 NZ NZ527051A patent/NZ527051A/en unknown
- 2002-01-18 KR KR10-2003-7009699A patent/KR20030068591A/ko not_active Withdrawn
- 2002-01-18 PL PL02364568A patent/PL364568A1/xx not_active Application Discontinuation
- 2002-01-18 WO PCT/US2002/001950 patent/WO2002059088A1/en not_active Ceased
- 2002-01-18 EA EA200300829A patent/EA006057B1/ru not_active IP Right Cessation
- 2002-01-18 CN CNB028067576A patent/CN1273450C/zh not_active Expired - Fee Related
- 2002-01-18 MX MXPA03006479A patent/MXPA03006479A/es active IP Right Grant
- 2002-01-18 JP JP2002559390A patent/JP4208573B2/ja not_active Expired - Fee Related
- 2002-01-18 AU AU2002251811A patent/AU2002251811B2/en not_active Ceased
- 2002-01-18 CA CA002435566A patent/CA2435566A1/en not_active Abandoned
- 2002-01-18 DE DE60207815T patent/DE60207815T2/de not_active Expired - Lifetime
- 2002-01-18 IL IL15705902A patent/IL157059A0/xx unknown
- 2002-01-18 HU HU0401009A patent/HUP0401009A3/hu unknown
- 2002-01-18 ES ES02720837T patent/ES2250638T3/es not_active Expired - Lifetime
- 2002-01-18 EP EP02720837A patent/EP1353904B9/en not_active Expired - Lifetime
- 2002-01-22 US US10/055,365 patent/US6509357B1/en not_active Expired - Fee Related
- 2002-01-22 AR ARP020100210A patent/AR034203A1/es not_active Application Discontinuation
- 2002-12-09 US US10/314,726 patent/US6710069B2/en not_active Expired - Fee Related
2003
- 2003-07-22 NO NO20033300A patent/NO20033300L/no not_active Application Discontinuation
- 2003-08-21 ZA ZA200306542A patent/ZA200306542B/xx unknown
- 2003-10-28 US US10/695,490 patent/US20040092564A1/en not_active Abandoned
- 2003-10-29 US US10/696,433 patent/US6919354B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE312078T1 (de)	2005-12-15
CA2435566A1 (en)	2002-08-01
US6509357B1 (en)	2003-01-21
HUP0401009A2 (hu)	2004-08-30
HUP0401009A3 (en)	2004-10-28
CN1273450C (zh)	2006-09-06
NO20033300L (no)	2003-09-03
KR20030068591A (ko)	2003-08-21
AU2002251811B2 (en)	2007-06-21
ZA200306542B (en)	2005-11-21
AR034203A1 (es)	2004-02-04
US6710069B2 (en)	2004-03-23
PL364568A1 (en)	2004-12-13
JP2004521116A (ja)	2004-07-15
DE60207815T2 (de)	2006-08-24
NO20033300D0 (no)	2003-07-22
US6919354B2 (en)	2005-07-19
EA006057B1 (ru)	2005-08-25
EP1353904A1 (en)	2003-10-22
EA200300829A1 (ru)	2003-12-25
CN1498209A (zh)	2004-05-19
BR0206633A (pt)	2004-02-17
DE60207815D1 (de)	2006-01-12
NZ527051A (en)	2005-07-29
TW593278B (en)	2004-06-21
US20040087637A1 (en)	2004-05-06
US20030149018A1 (en)	2003-08-07
IL157059A0 (en)	2004-02-08
JP4208573B2 (ja)	2009-01-14
US20040092564A1 (en)	2004-05-13
EP1353904B1 (en)	2005-12-07
WO2002059088A1 (en)	2002-08-01
MXPA03006479A (es)	2003-09-22
EP1353904B9 (en)	2006-05-03
ES2250638T3 (es)	2006-04-16

Publication	Publication Date	Title
DK1353904T3 (da)	2006-02-20	1-Aryl- eller 1-alkylsulfonylbenzazolderivater som 5-hydroxytryptamin-6-ligander
NO20031977L (no)	2003-06-30	1-aryl- eller 1-alkylsulfonyl-heterocyklylbenzazoler som 5- hydroksytryptamin-6-ligander
DK1456206T3 (da)	2008-09-08	Azaindolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
DK1455779T3 (da)	2006-10-30	Indolylalkylaminderivater som 5-hydroxytryptamin-6-ligander
DK1355904T3 (da)	2007-10-15	Heterocyclindazol- og -azaindazolforbindelser som 5-hydroxytryptamin-6-ligander
DK1509522T3 (da)	2007-04-16	1-(Aminoalkyl)-3-sulfonylazaindoler som 5-hydroxytryptamin-6-ligander
DK1414803T3 (da)	2013-03-25	Pyrazolylcarboxanilider som fungicider
NO20034648L (no)	2003-11-20	Hydroksycyklyloksy-, tioksy- og -aminobenzazol-derivater som 5-hydroksytryptamin-6-ligander
NO20035775L (no)	2004-02-23	3-fluor-pyrrolidiner som anti-diabetesmidler
IL166138A0 (en)	2006-01-15	1-heterocyclylalkyl-3-sulfonylindole or indazole derivatives as 5-hydroxytryptamine-6 ligands
IL166139A0 (en)	2006-01-15	1-heterocycylalkyl-3-sulfonylazaindole or- azaindazole derivatives as 5-hydroxytryptamine-6 ligands
NO20032531D0 (no)	2003-06-04	Tetralon-derivater som antitumormidler
DK1355900T3 (da)	2006-09-11	Heterocyclylalkylindol- eller -azaindolforbindelser som 5-hydroxytryptamin-6-ligander
DK1509501T3 (da)	2007-03-12	1-(Aminoalkyl)-3-sulfonylindol- og indazolderivater som 5-hydroxytryptamin-6-ligander
DE50209511D1 (de)	2007-04-05	Kreiselpumpe
DK1429607T3 (da)	2007-08-13	Delta-1-pyrroliner som pesticider
NO20034647D0 (no)	2003-10-17	Hydroksyclylalkoksy-, alkyloksy- og -alkylaminobenzazol- derivater som 5-hydroksytryptamin-6-ligander
DK1322654T3 (da)	2009-04-14	Platinkomplekser som antitumormidler
NO20033234L (no)	2003-09-22	Karotenoider som antihypertensjonsmidler
HK1066002A (en)	2005-04-15	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
HK1056561A (en)	2004-02-20	1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
HK1060880A (en)	2004-08-27	Heterocyclylalkoxy-, -alkylthio- and - alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
HK1060128A (en)	2004-07-30	Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands